You are here: Industry Insights > Hikma

News List

Hikma, Civica Rx Ink Generic Drug Shortage Deal contractpharma
July 24, 2019
Partnership will supply 14 essential medicines to U.S. hospitals and patients.
Hikma introduces 100th injectable medicine in US pharmaceutical-technology
May 05, 2019
Hikma Pharmaceuticals has launched its 100th injectable medicine in the US.
Hikma rises on cancer generic deal with China’s Hansoh pharmaphorum
November 30, 2018
UK-listed Hikma Pharma has licensed an array of injectable cancer drugs from China’s Hansoh, sparking a rise in its share price....
Hikma, Vectura to develop generic rivals to GSK's Ellipta portfolio pharmatimes
November 12, 2018
Following interactions with US regulators, the firms believe the inhaler device has the potential to be developed as a substitutable drug-device combination for generic versions of the GSK Ellipta portfolio.
Hikma acquires Medlac Pharma biospectrum
November 12, 2018
Driven by a growing population, government healthcare reforms and strong economic development, Vietnam has been the fastest growing pharmaceutical market in South East Asia in recent years and this fast-paced growth is expected to continue.
Hikma to produce injectables in Vietnam with deal for Medlac Pharma Italy fiercepharma
November 11, 2018
Hikma Wednesday said it had a deal to buy Medlac Pharma Italy Co., a Vietnamese injectables manufacturing company established a decade ago as a Vietnamese and Italian joint venture. The acquisition includes an injectables facility in Hanoi which began pro
Vectura and Hikma to jointly develop generic versions of GSK’s Ellipta americanpharmaceuticalreviewpharmaceutical-technol
November 10, 2018
UK-based drug manufacturers Vectura Group and Hikma Pharmaceuticals have collaborated to develop and commercialise a generic version of GSK’s Ellipta inhaler products indicated for respiratory conditions.
Hikma acquires Medlac, an injectable manufacturing company in Vietnam firstwordpharma
November 09, 2018
Today announces that Hikma has entered into an agreement to acquire 100 per cent of the share capital of Medlac Pharma Italy Co. Ltd. (Medlac)...
Hikma to ease U.S. hydromorphone shortage; FDA gives nod to Terumo BCT to boost anticoagulant stocks fiercepharma
July 27, 2018
Generics maker Hikma is looking to ease the U.S. shortage of hydromorphone with increased production as the FDA gave its OK to Terumo BCT to shore up short supplies of anticoagulant solution.
Granules Pharmaceuticals, Hikma launch generic Methylergonovine tablets financialexpress
June 01, 2018
Granules Pharmaceuticals, the wholly-owned subsidiary of Granules India , has launched the generic version of Methylergonovine Maleate Tablets, USP, 0.2mg,

Previous page 1 2 3 Next page